© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress
BHF Laboratories, Centre for Clinical Pharmacology, Department of Medicine, University College London, Rayne Institute, 5 University Street, London WC1E 6JJ, United Kingdom
* Corresponding author. Tel.: +44 20 7679 6205; fax: +44 20 7679 6211. E-mail address: b.clapp{at}ucl.ac.uk
Objectives: Our aim was to investigate mechanisms of inflammation-induced endothelial dysfunction in humans. Methods: Endothelial function in twenty-one healthy human volunteers was measured using forearm venous plethysmography before and 8 h after administration of typhoid vaccination to generate an inflammatory response. Basal and stimulated endothelial nitric oxide (NO) bioavailability was assessed by measurement of the responses to intra-arterial NG-monomethyl-L-arginine (L-NMMA) and bradykinin, respectively. The effects of supplementation with L-arginine or ascorbic acid were assessed to probe the effects of substrate deficiency and oxidative stress, respectively. Systemic effects were determined by measuring cytokine response, total anti-oxidant status (TAOS) and urinary protein excretion. Results: Vaccination induced a cytokine response, a fall in total anti-oxidant status and increased urinary albumin excretion (UAE). There was a reduction in the response to bradykinin (BK, P<0.005) and L-NMMA (P<0.0001) with no effect on the response to glyceryl trinitrate (GTN) and norepinephrine (NE). Following vaccination blood flow response to BK (but not GTN) was partially returned to pre-vaccine levels by infusion of ascorbic acid (P=0.01). Supplementation with L-arginine had no effect. Conclusion: Inflammation causes widespread endothelial dysfunction, reduces vascular NO bioavailability and increases oxidative stress. These actions are partially reversible with local anti-oxidants. These findings suggest a role for reactive oxygen species in inflammation-induced endothelial dysfunction.
KEYWORDS Endothelium; Nitric oxide; Inflammation; Coronary disease; Reactive oxygen species
Abbreviations: AUC, area under the curve • BH4, tetrahydrobiopterin • BK, bradykinin • GTN, glyceryl trinitrate • IL, interleukin • IL-1Ra, interleukin-1 receptor antagonist • L-NMMA, NG-monomethyl-L-arginine • NE, norepinephrine • NO, nitric oxide • NOS, nitric oxide synthase • TAOS, total anti-oxidant status • UAC, urinary albumin/creatinine ratio • UAE, urinary albumin excretion
Time for primary review 32 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Imrie, A. Abbas, H. Viswambharan, A. Rajwani, R. M. Cubbon, M. Gage, M. Kahn, V. A. Ezzat, E. R. Duncan, P. J. Grant, et al. Vascular Insulin-Like Growth Factor-I Resistance and Diet-Induced Obesity Endocrinology, October 1, 2009; 150(10): 4575 - 4582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Sharif, U. Bayraktutan, N. Arya, S. A. Badger, M. E. O'Donnell, I. S. Young, and C. V. Soong Effects of Antioxidants on Endothelial Function in Human Saphenous Vein in an Ex vivo Model Angiology, August 1, 2009; 60(4): 448 - 454. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Sennoun, C. Baron-Menguy, M. Burban, T. Lecompte, R. Andriantsitohaina, D. Henrion, A. Mercat, P. Asfar, B. Levy, and F. Meziani Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H277 - H282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Foster, J. V. Brugniaux, V. Pialoux, C. T. C. Duggan, P. J. Hanly, S. B. Ahmed, and M. J. Poulin Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans J. Physiol., July 1, 2009; 587(13): 3287 - 3299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ponnuchamy and R. A. Khalil Cellular mediators of renal vascular dysfunction in hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1001 - R1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Yilmaz, H Mahrholdt, A Athanasiadis, H Vogelsberg, G Meinhardt, M Voehringer, E-M Kispert, C Deluigi, H Baccouche, E Spodarev, et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis Heart, November 1, 2008; 94(11): 1456 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. C. Davel, L. E. Fukuda, L. L. De Sa, C. D. Munhoz, C. Scavone, D. Sanz-Rosa, V. Cachofeiro, V. Lahera, and L. V. Rossoni Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H211 - H219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Kearney, E. R. Duncan, M. Kahn, and S. B. Wheatcroft Insulin resistance and endothelial cell dysfunction: studies in mammalian models Exp Physiol, January 1, 2008; 93(1): 158 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Meziani, H. Kremer, A. Tesse, C. Baron-Menguy, C. Mathien, H. A. Mostefai, N. Carusio, F. Schneider, P. Asfar, and R. Andriantsitohaina Human Serum Albumin Improves Arterial Dysfunction during Early Resuscitation in Mouse Endotoxic Model via Reduced Oxidative and Nitrosative Stresses Am. J. Pathol., December 1, 2007; 171(6): 1753 - 1761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vlachopoulos, K. Aznaouridis, A. Dagre, C. Vasiliadou, C. Masoura, E. Stefanadi, J. Skoumas, C. Pitsavos, and C. Stefanadis Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects Eur. Heart J., September 1, 2007; 28(17): 2102 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vlachopoulos, K. Aznaouridis, N. Ioakeimidis, K. Rokkas, C. Vasiliadou, N. Alexopoulos, E. Stefanadi, A. Askitis, and C. Stefanadis Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease Eur. Heart J., November 2, 2006; 27(22): 2640 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L Williams, P. J Chowienczyk, S. B Wheatcroft, A. G Patel, R. A Sherwood, A. M Shah, and M. T Kearney Divergent effects of angiotensin-converting enzyme inhibition on blood pressure and endothelial function in obese humans Diabetes and Vascular Disease Research, May 1, 2006; 3(1): 34 - 38. [Abstract] [PDF]
|
|
|
|
 |
|
 R. P Raghavan, D. W Laight, K. M Shaw, and M. H Cummings Review: Aspirin and diabetes The British Journal of Diabetes & Vascular Disease, March 1, 2006; 6(2): 74 - 82. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Vlachopoulos, I. Dima, K. Aznaouridis, C. Vasiliadou, N. Ioakeimidis, C. Aggeli, M. Toutouza, and C. Stefanadis Acute Systemic Inflammation Increases Arterial Stiffness and Decreases Wave Reflections in Healthy Individuals Circulation, October 4, 2005; 112(14): 2193 - 2200. [Abstract] [Full Text] [PDF]
|
|